Back to GNMSF
Paradigm Biocapital Advisors LP → GNMSF
Paradigm Biocapital Advisors LP GNMSF Position History
Genmab A/S • Healthcare
Quarters held
4
Latest value
$504.3M
Q3 2026
Peak value
$504.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $216.8M |
| Q1 2026 | $213.8M |
| Q2 2026 | $360.8M |
| Q3 2026 | $504.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $504.3M | 14.14M | — | — |
| Q2 2026 | $360.8M | 13.13M | — | — |
| Q1 2026 | $213.8M | 7.97M | — | — |
| Q4 2025 | $216.8M | 7.04M | — | — |
Other funds holding GNMSF
$443.1M
$376.1M
$345.9M
$311.4M
$294.4M